http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2024, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Fri, 19 Jul 2024 09:22:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/SEC+Filings/Form++25-NSE+++++DermTech%2C+Inc.+++++++++++++++++++++++++Filed+by%3A+Nasdaq+Stock+Market+LLC/23482382.html si-local-file:///var/storage/secattach/20240719/23482382.html http://www.streetinsider.com/SEC+Filings/Form++25-NSE+++++DermTech%2C+Inc.+++++++++++++++++++++++++Filed+by%3A+Nasdaq+Stock+Market+LLC/23482382.html Fri, 19 Jul 2024 09:22:00 -0400 DMTK O.46180359 http://www.streetinsider.com/SEC+Filings/Form++25-NSE+++++DermTech%2C+Inc.+++++++++++++++++++++++++Filed+by%3A+Nasdaq+Stock+Market+LLC/23482382.html si-local-file:///var/storage/secattach/20240719/23482382.html http://www.streetinsider.com/SEC+Filings/Form++25-NSE+++++DermTech%2C+Inc.+++++++++++++++++++++++++Filed+by%3A+Nasdaq+Stock+Market+LLC/23482382.html Fri, 19 Jul 2024 09:22:00 -0400 DMTK O.46180359 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++DermTech%2C+Inc.++++++++++++For%3A+Jun+18/23379568.html si-local-file:///var/storage/secattach/20240620/23379568.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++DermTech%2C+Inc.++++++++++++For%3A+Jun+18/23379568.html Thu, 20 Jun 2024 16:04:00 -0400 DMTK O.46180359 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++DermTech%2C+Inc.++++++++++++For%3A+Jun+18/23379568.html si-local-file:///var/storage/secattach/20240620/23379568.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++DermTech%2C+Inc.++++++++++++For%3A+Jun+18/23379568.html Thu, 20 Jun 2024 16:04:00 -0400 DMTK O.46180359 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++DermTech%2C+Inc.++++++++++++For%3A+Jun+12/23369532.html si-local-file:///var/storage/secattach/20240618/23369532.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++DermTech%2C+Inc.++++++++++++For%3A+Jun+12/23369532.html Tue, 18 Jun 2024 08:10:00 -0400 DMTK O.46180359 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++DermTech%2C+Inc.++++++++++++For%3A+Jun+12/23369532.html si-local-file:///var/storage/secattach/20240618/23369532.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++DermTech%2C+Inc.++++++++++++For%3A+Jun+12/23369532.html Tue, 18 Jun 2024 08:10:00 -0400 DMTK O.46180359 http://www.streetinsider.com/Corporate+News/DermTech+%28DMTK%29+Files+for+Voluntary+Chapter+11+Protection/23369511.html <p>DermTech, Inc. (NASDAQ: DMTK) (DermTech or the Company), a leader in precision dermatology enabled by a non-invasive skin genomics technology, today filed for voluntary chapter 11 protection in the U.S. Bankruptcy Court for the District of Delaware. The chapter 11 filing is a continuation of the Company’s strategic alternatives review process. Currently, the Company intends to continue its laboratory operations and processing orders for the DermTech Melanoma Test (DMT), while simultaneously conducting a process to sell substantially all of its assets. Through the bankruptcy process, the Company intends to safeguard the interest of stakeholders and maximize the value of its http://www.streetinsider.com/Corporate+News/DermTech+%28DMTK%29+Files+for+Voluntary+Chapter+11+Protection/23369511.html Tue, 18 Jun 2024 08:05:34 -0400 DMTK http://www.streetinsider.com/Press+Releases/DermTech+Files+for+Voluntary+Chapter+11+Protection/23369505.html <p> SAN DIEGO--(BUSINESS WIRE)-- DermTech, Inc. (NASDAQ: DMTK) (DermTech or the Company), a leader in precision dermatology enabled by a non-invasive skin genomics technology, today filed for voluntary chapter 11 protection in the U.S. Bankruptcy Court for the District of Delaware. The chapter 11 filing is a continuation of the Company’s strategic alternatives review process. Currently, the Company intends to continue its laboratory operations and processing orders for the DermTech Melanoma Test (DMT), while simultaneously conducting a process to sell substantially all of its assets. Through the bankruptcy process, the Company intends to safeguard the interest of stakeholders http://www.streetinsider.com/Press+Releases/DermTech+Files+for+Voluntary+Chapter+11+Protection/23369505.html Tue, 18 Jun 2024 08:05:00 -0400 A.19658497 A.22194166 A.50100012 DMTK O.00053334 O.05948807 O.07579093 O.46180359 http://www.streetinsider.com/Press+Releases/DermTech+Files+for+Voluntary+Chapter+11+Protection/23369505.html <p> SAN DIEGO--(BUSINESS WIRE)-- DermTech, Inc. (NASDAQ: DMTK) (DermTech or the Company), a leader in precision dermatology enabled by a non-invasive skin genomics technology, today filed for voluntary chapter 11 protection in the U.S. Bankruptcy Court for the District of Delaware. The chapter 11 filing is a continuation of the Company’s strategic alternatives review process. Currently, the Company intends to continue its laboratory operations and processing orders for the DermTech Melanoma Test (DMT), while simultaneously conducting a process to sell substantially all of its assets. Through the bankruptcy process, the Company intends to safeguard the interest of stakeholders http://www.streetinsider.com/Press+Releases/DermTech+Files+for+Voluntary+Chapter+11+Protection/23369505.html Tue, 18 Jun 2024 08:05:00 -0400 A.19658497 A.22194166 A.50100012 DMTK O.00053334 O.05948807 O.07579093 O.46180359 http://www.streetinsider.com/Press+Releases/DermTech+Files+for+Voluntary+Chapter+11+Protection/23369505.html <p> SAN DIEGO--(BUSINESS WIRE)-- DermTech, Inc. (NASDAQ: DMTK) (DermTech or the Company), a leader in precision dermatology enabled by a non-invasive skin genomics technology, today filed for voluntary chapter 11 protection in the U.S. Bankruptcy Court for the District of Delaware. The chapter 11 filing is a continuation of the Company’s strategic alternatives review process. Currently, the Company intends to continue its laboratory operations and processing orders for the DermTech Melanoma Test (DMT), while simultaneously conducting a process to sell substantially all of its assets. Through the bankruptcy process, the Company intends to safeguard the interest of stakeholders http://www.streetinsider.com/Press+Releases/DermTech+Files+for+Voluntary+Chapter+11+Protection/23369505.html Tue, 18 Jun 2024 08:05:00 -0400 A.19658497 A.22194166 A.50100012 DMTK O.00053334 O.05948807 O.07579093 O.46180359 http://www.streetinsider.com/Press+Releases/DermTech+Files+for+Voluntary+Chapter+11+Protection/23369505.html <p> SAN DIEGO--(BUSINESS WIRE)-- DermTech, Inc. (NASDAQ: DMTK) (DermTech or the Company), a leader in precision dermatology enabled by a non-invasive skin genomics technology, today filed for voluntary chapter 11 protection in the U.S. Bankruptcy Court for the District of Delaware. The chapter 11 filing is a continuation of the Company’s strategic alternatives review process. Currently, the Company intends to continue its laboratory operations and processing orders for the DermTech Melanoma Test (DMT), while simultaneously conducting a process to sell substantially all of its assets. Through the bankruptcy process, the Company intends to safeguard the interest of stakeholders http://www.streetinsider.com/Press+Releases/DermTech+Files+for+Voluntary+Chapter+11+Protection/23369505.html Tue, 18 Jun 2024 08:05:00 -0400 A.19658497 A.22194166 A.50100012 DMTK O.00053334 O.05948807 O.07579093 O.46180359 http://www.streetinsider.com/Press+Releases/DermTech+Files+for+Voluntary+Chapter+11+Protection/23369505.html <p> SAN DIEGO--(BUSINESS WIRE)-- DermTech, Inc. (NASDAQ: DMTK) (DermTech or the Company), a leader in precision dermatology enabled by a non-invasive skin genomics technology, today filed for voluntary chapter 11 protection in the U.S. Bankruptcy Court for the District of Delaware. The chapter 11 filing is a continuation of the Company’s strategic alternatives review process. Currently, the Company intends to continue its laboratory operations and processing orders for the DermTech Melanoma Test (DMT), while simultaneously conducting a process to sell substantially all of its assets. Through the bankruptcy process, the Company intends to safeguard the interest of stakeholders http://www.streetinsider.com/Press+Releases/DermTech+Files+for+Voluntary+Chapter+11+Protection/23369505.html Tue, 18 Jun 2024 08:05:00 -0400 A.19658497 A.22194166 A.50100012 DMTK O.00053334 O.05948807 O.07579093 O.46180359 http://www.streetinsider.com/Press+Releases/DermTech+Files+for+Voluntary+Chapter+11+Protection/23369505.html <p> SAN DIEGO--(BUSINESS WIRE)-- DermTech, Inc. (NASDAQ: DMTK) (DermTech or the Company), a leader in precision dermatology enabled by a non-invasive skin genomics technology, today filed for voluntary chapter 11 protection in the U.S. Bankruptcy Court for the District of Delaware. The chapter 11 filing is a continuation of the Company’s strategic alternatives review process. Currently, the Company intends to continue its laboratory operations and processing orders for the DermTech Melanoma Test (DMT), while simultaneously conducting a process to sell substantially all of its assets. Through the bankruptcy process, the Company intends to safeguard the interest of stakeholders http://www.streetinsider.com/Press+Releases/DermTech+Files+for+Voluntary+Chapter+11+Protection/23369505.html Tue, 18 Jun 2024 08:05:00 -0400 A.19658497 A.22194166 A.50100012 DMTK O.00053334 O.05948807 O.07579093 O.46180359 http://www.streetinsider.com/Press+Releases/DermTech+Files+for+Voluntary+Chapter+11+Protection/23369505.html <p> SAN DIEGO--(BUSINESS WIRE)-- DermTech, Inc. (NASDAQ: DMTK) (DermTech or the Company), a leader in precision dermatology enabled by a non-invasive skin genomics technology, today filed for voluntary chapter 11 protection in the U.S. Bankruptcy Court for the District of Delaware. The chapter 11 filing is a continuation of the Company’s strategic alternatives review process. Currently, the Company intends to continue its laboratory operations and processing orders for the DermTech Melanoma Test (DMT), while simultaneously conducting a process to sell substantially all of its assets. Through the bankruptcy process, the Company intends to safeguard the interest of stakeholders http://www.streetinsider.com/Press+Releases/DermTech+Files+for+Voluntary+Chapter+11+Protection/23369505.html Tue, 18 Jun 2024 08:05:00 -0400 A.19658497 A.22194166 A.50100012 DMTK O.00053334 O.05948807 O.07579093 O.46180359 http://www.streetinsider.com/Press+Releases/DermTech+Files+for+Voluntary+Chapter+11+Protection/23369505.html <p> SAN DIEGO--(BUSINESS WIRE)-- DermTech, Inc. (NASDAQ: DMTK) (DermTech or the Company), a leader in precision dermatology enabled by a non-invasive skin genomics technology, today filed for voluntary chapter 11 protection in the U.S. Bankruptcy Court for the District of Delaware. The chapter 11 filing is a continuation of the Company’s strategic alternatives review process. Currently, the Company intends to continue its laboratory operations and processing orders for the DermTech Melanoma Test (DMT), while simultaneously conducting a process to sell substantially all of its assets. Through the bankruptcy process, the Company intends to safeguard the interest of stakeholders http://www.streetinsider.com/Press+Releases/DermTech+Files+for+Voluntary+Chapter+11+Protection/23369505.html Tue, 18 Jun 2024 08:05:00 -0400 A.19658497 A.22194166 A.50100012 DMTK O.00053334 O.05948807 O.07579093 O.46180359 http://www.streetinsider.com/Business+Wire/DermTech+Files+for+Voluntary+Chapter+11+Protection/23369505.html <p> SAN DIEGO--(BUSINESS WIRE)-- DermTech, Inc. (NASDAQ: DMTK) (DermTech or the Company), a leader in precision dermatology enabled by a non-invasive skin genomics technology, today filed for voluntary chapter 11 protection in the U.S. Bankruptcy Court for the District of Delaware. The chapter 11 filing is a continuation of the Company’s strategic alternatives review process. Currently, the Company intends to continue its laboratory operations and processing orders for the DermTech Melanoma Test (DMT), while simultaneously conducting a process to sell substantially all of its assets. Through the bankruptcy process, the Company intends to safeguard the interest of stakeholders http://www.streetinsider.com/Business+Wire/DermTech+Files+for+Voluntary+Chapter+11+Protection/23369505.html Tue, 18 Jun 2024 08:05:00 -0400 A.19658497 A.22194166 A.50100012 DMTK O.00053334 O.05948807 O.07579093 O.46180359 http://www.streetinsider.com/Business+Wire/DermTech+Files+for+Voluntary+Chapter+11+Protection/23369505.html <p> SAN DIEGO--(BUSINESS WIRE)-- DermTech, Inc. (NASDAQ: DMTK) (DermTech or the Company), a leader in precision dermatology enabled by a non-invasive skin genomics technology, today filed for voluntary chapter 11 protection in the U.S. Bankruptcy Court for the District of Delaware. The chapter 11 filing is a continuation of the Company’s strategic alternatives review process. Currently, the Company intends to continue its laboratory operations and processing orders for the DermTech Melanoma Test (DMT), while simultaneously conducting a process to sell substantially all of its assets. Through the bankruptcy process, the Company intends to safeguard the interest of stakeholders http://www.streetinsider.com/Business+Wire/DermTech+Files+for+Voluntary+Chapter+11+Protection/23369505.html Tue, 18 Jun 2024 08:05:00 -0400 A.19658497 A.22194166 A.50100012 DMTK O.00053334 O.05948807 O.07579093 O.46180359 http://www.streetinsider.com/Business+Wire/DermTech+Files+for+Voluntary+Chapter+11+Protection/23369505.html <p> SAN DIEGO--(BUSINESS WIRE)-- DermTech, Inc. (NASDAQ: DMTK) (DermTech or the Company), a leader in precision dermatology enabled by a non-invasive skin genomics technology, today filed for voluntary chapter 11 protection in the U.S. Bankruptcy Court for the District of Delaware. The chapter 11 filing is a continuation of the Company’s strategic alternatives review process. Currently, the Company intends to continue its laboratory operations and processing orders for the DermTech Melanoma Test (DMT), while simultaneously conducting a process to sell substantially all of its assets. Through the bankruptcy process, the Company intends to safeguard the interest of stakeholders http://www.streetinsider.com/Business+Wire/DermTech+Files+for+Voluntary+Chapter+11+Protection/23369505.html Tue, 18 Jun 2024 08:05:00 -0400 A.19658497 A.22194166 A.50100012 DMTK O.00053334 O.05948807 O.07579093 O.46180359 http://www.streetinsider.com/Business+Wire/DermTech+Files+for+Voluntary+Chapter+11+Protection/23369505.html <p> SAN DIEGO--(BUSINESS WIRE)-- DermTech, Inc. (NASDAQ: DMTK) (DermTech or the Company), a leader in precision dermatology enabled by a non-invasive skin genomics technology, today filed for voluntary chapter 11 protection in the U.S. Bankruptcy Court for the District of Delaware. The chapter 11 filing is a continuation of the Company’s strategic alternatives review process. Currently, the Company intends to continue its laboratory operations and processing orders for the DermTech Melanoma Test (DMT), while simultaneously conducting a process to sell substantially all of its assets. Through the bankruptcy process, the Company intends to safeguard the interest of stakeholders http://www.streetinsider.com/Business+Wire/DermTech+Files+for+Voluntary+Chapter+11+Protection/23369505.html Tue, 18 Jun 2024 08:05:00 -0400 A.19658497 A.22194166 A.50100012 DMTK O.00053334 O.05948807 O.07579093 O.46180359 http://www.streetinsider.com/Business+Wire/DermTech+Files+for+Voluntary+Chapter+11+Protection/23369505.html <p> SAN DIEGO--(BUSINESS WIRE)-- DermTech, Inc. (NASDAQ: DMTK) (DermTech or the Company), a leader in precision dermatology enabled by a non-invasive skin genomics technology, today filed for voluntary chapter 11 protection in the U.S. Bankruptcy Court for the District of Delaware. The chapter 11 filing is a continuation of the Company’s strategic alternatives review process. Currently, the Company intends to continue its laboratory operations and processing orders for the DermTech Melanoma Test (DMT), while simultaneously conducting a process to sell substantially all of its assets. Through the bankruptcy process, the Company intends to safeguard the interest of stakeholders http://www.streetinsider.com/Business+Wire/DermTech+Files+for+Voluntary+Chapter+11+Protection/23369505.html Tue, 18 Jun 2024 08:05:00 -0400 A.19658497 A.22194166 A.50100012 DMTK O.00053334 O.05948807 O.07579093 O.46180359 http://www.streetinsider.com/Business+Wire/DermTech+Files+for+Voluntary+Chapter+11+Protection/23369505.html <p> SAN DIEGO--(BUSINESS WIRE)-- DermTech, Inc. (NASDAQ: DMTK) (DermTech or the Company), a leader in precision dermatology enabled by a non-invasive skin genomics technology, today filed for voluntary chapter 11 protection in the U.S. Bankruptcy Court for the District of Delaware. The chapter 11 filing is a continuation of the Company’s strategic alternatives review process. Currently, the Company intends to continue its laboratory operations and processing orders for the DermTech Melanoma Test (DMT), while simultaneously conducting a process to sell substantially all of its assets. Through the bankruptcy process, the Company intends to safeguard the interest of stakeholders http://www.streetinsider.com/Business+Wire/DermTech+Files+for+Voluntary+Chapter+11+Protection/23369505.html Tue, 18 Jun 2024 08:05:00 -0400 A.19658497 A.22194166 A.50100012 DMTK O.00053334 O.05948807 O.07579093 O.46180359 http://www.streetinsider.com/Business+Wire/DermTech+Files+for+Voluntary+Chapter+11+Protection/23369505.html <p> SAN DIEGO--(BUSINESS WIRE)-- DermTech, Inc. (NASDAQ: DMTK) (DermTech or the Company), a leader in precision dermatology enabled by a non-invasive skin genomics technology, today filed for voluntary chapter 11 protection in the U.S. Bankruptcy Court for the District of Delaware. The chapter 11 filing is a continuation of the Company’s strategic alternatives review process. Currently, the Company intends to continue its laboratory operations and processing orders for the DermTech Melanoma Test (DMT), while simultaneously conducting a process to sell substantially all of its assets. Through the bankruptcy process, the Company intends to safeguard the interest of stakeholders http://www.streetinsider.com/Business+Wire/DermTech+Files+for+Voluntary+Chapter+11+Protection/23369505.html Tue, 18 Jun 2024 08:05:00 -0400 A.19658497 A.22194166 A.50100012 DMTK O.00053334 O.05948807 O.07579093 O.46180359 http://www.streetinsider.com/Business+Wire/DermTech+Files+for+Voluntary+Chapter+11+Protection/23369505.html <p> SAN DIEGO--(BUSINESS WIRE)-- DermTech, Inc. (NASDAQ: DMTK) (DermTech or the Company), a leader in precision dermatology enabled by a non-invasive skin genomics technology, today filed for voluntary chapter 11 protection in the U.S. Bankruptcy Court for the District of Delaware. The chapter 11 filing is a continuation of the Company’s strategic alternatives review process. Currently, the Company intends to continue its laboratory operations and processing orders for the DermTech Melanoma Test (DMT), while simultaneously conducting a process to sell substantially all of its assets. Through the bankruptcy process, the Company intends to safeguard the interest of stakeholders http://www.streetinsider.com/Business+Wire/DermTech+Files+for+Voluntary+Chapter+11+Protection/23369505.html Tue, 18 Jun 2024 08:05:00 -0400 A.19658497 A.22194166 A.50100012 DMTK O.00053334 O.05948807 O.07579093 O.46180359 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++DermTech%2C+Inc.++++++++++++For%3A+Jun+10++Filed+by%3A+Sun+Kevin+M/23354182.html si-local-file:///var/storage/secattach/20240612/23354182.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++DermTech%2C+Inc.++++++++++++For%3A+Jun+10++Filed+by%3A+Sun+Kevin+M/23354182.html Wed, 12 Jun 2024 20:07:00 -0400 DMTK O.46180359 http://www.streetinsider.com/SEC+Filings/Form++4++++++++++DermTech%2C+Inc.++++++++++++For%3A+Jun+10++Filed+by%3A+Sun+Kevin+M/23354182.html si-local-file:///var/storage/secattach/20240612/23354182.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++DermTech%2C+Inc.++++++++++++For%3A+Jun+10++Filed+by%3A+Sun+Kevin+M/23354182.html Wed, 12 Jun 2024 20:07:00 -0400 DMTK O.46180359